Provectus Pharmaceuticals, Inc. (OTC:PVCT) is on the progressive move these days. Yesterday, the stock soared the next 
7.53%, while trading over 330 thousand shares on the market.
Following the records, only one reason for the sudden up move can be found – high trading activity with shares of PVCT common stock. During the past three days, the management of Provectus has been massively buying huge amounts of the company’s shares and PVCT stock price immediately jumped up.
As Provectus has not filed any news on its business lately, no more updates on the company’s activities can be found. Though, the high trading activity appears to be a successful strategy as PVCT reached $1.00 per share. Now, the question is how far the climb may go?
Anyway, the big issue for Provectus remain their financials. According to its 10-Q report, the company has reported:
* $14,390,120 cash and cash equivalents
* $5,692,530 total liabilities
* Preferred stock of 4.2 million issued and outstanding
* 17.3 million shares of common stock issued since Dec 31, 2010[BANNER]
It seems that Provectus had more than enough cash and cash equivalents at hand to cover its current liabilities, even after recording a $5.3 million operating loss for the quarter.
However, the company is not generating any revenues and finances its operations through the sale of equity and warrants. Also, the report shows some dilution that may discourage investors.
